左心室辅助装置患者中的严重肥胖症患者

IF 3.7 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS American heart journal Pub Date : 2024-06-10 DOI:10.1016/j.ahj.2024.05.006
Cathlyn K Medina MD , Stephanie G Barnes PhD , G Michael Felker MD, MHS , Robert J Mentz MD , Neha J Pagidipati MD , Keri A Seymour DO , Jacob N Schroder MD , Josephine Harrington MD
{"title":"左心室辅助装置患者中的严重肥胖症患者","authors":"Cathlyn K Medina MD ,&nbsp;Stephanie G Barnes PhD ,&nbsp;G Michael Felker MD, MHS ,&nbsp;Robert J Mentz MD ,&nbsp;Neha J Pagidipati MD ,&nbsp;Keri A Seymour DO ,&nbsp;Jacob N Schroder MD ,&nbsp;Josephine Harrington MD","doi":"10.1016/j.ahj.2024.05.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Patients with obesity and advanced heart failure requiring left ventricular assist device (LVAD) support are more likely to experience LVAD complications and may be disproportionately Black and/or female when compared to patients without obesity. Among these patients, obesity may represent a barrier to transplant eligibility and a marker of inequity in heart transplantation and health outcomes in advanced heart failure.</p></div><div><h3>Methods</h3><p>To better understand this issue at our institution, we examined our active LVAD cohort and found that almost one-third of all patients had severe obesity with BMI ≥ 35 kg/m<sup>2</sup>.</p></div><div><h3>Results</h3><p>Patients with LVADs and severe obesity were significantly younger and more likely to self-identify as Black, and numerically more likely to be female.</p></div><div><h3>Conclusion</h3><p>Weight management in this group represents a vital area for improved equity in health outcomes and barriers to heart transplantation.</p></div><div><h3>Trial Registration</h3><p>NA.</p></div>","PeriodicalId":7868,"journal":{"name":"American heart journal","volume":"274 ","pages":"Pages 130-133"},"PeriodicalIF":3.7000,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Severe obesity among patients with left ventricular assist devices\",\"authors\":\"Cathlyn K Medina MD ,&nbsp;Stephanie G Barnes PhD ,&nbsp;G Michael Felker MD, MHS ,&nbsp;Robert J Mentz MD ,&nbsp;Neha J Pagidipati MD ,&nbsp;Keri A Seymour DO ,&nbsp;Jacob N Schroder MD ,&nbsp;Josephine Harrington MD\",\"doi\":\"10.1016/j.ahj.2024.05.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Patients with obesity and advanced heart failure requiring left ventricular assist device (LVAD) support are more likely to experience LVAD complications and may be disproportionately Black and/or female when compared to patients without obesity. Among these patients, obesity may represent a barrier to transplant eligibility and a marker of inequity in heart transplantation and health outcomes in advanced heart failure.</p></div><div><h3>Methods</h3><p>To better understand this issue at our institution, we examined our active LVAD cohort and found that almost one-third of all patients had severe obesity with BMI ≥ 35 kg/m<sup>2</sup>.</p></div><div><h3>Results</h3><p>Patients with LVADs and severe obesity were significantly younger and more likely to self-identify as Black, and numerically more likely to be female.</p></div><div><h3>Conclusion</h3><p>Weight management in this group represents a vital area for improved equity in health outcomes and barriers to heart transplantation.</p></div><div><h3>Trial Registration</h3><p>NA.</p></div>\",\"PeriodicalId\":7868,\"journal\":{\"name\":\"American heart journal\",\"volume\":\"274 \",\"pages\":\"Pages 130-133\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American heart journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0002870324001212\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American heart journal","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002870324001212","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景肥胖和需要左心室辅助装置(LVAD)支持的晚期心力衰竭患者更有可能出现 LVAD 并发症,而且与非肥胖患者相比,黑人和/或女性患者的比例可能更高。在这些患者中,肥胖可能是移植资格的一个障碍,也是心脏移植和晚期心衰健康结果不公平的一个标志。方法为了更好地了解本机构的这一问题,我们检查了正在使用 LVAD 的队列,发现几乎三分之一的患者有严重肥胖,BMI ≥ 35 kg/m2。结果患有 LVAD 且严重肥胖的患者明显更年轻,更有可能自认为是黑人,而且在人数上更有可能是女性。结论该群体的体重管理是改善健康结果公平性和心脏移植障碍的一个重要领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Severe obesity among patients with left ventricular assist devices

Background

Patients with obesity and advanced heart failure requiring left ventricular assist device (LVAD) support are more likely to experience LVAD complications and may be disproportionately Black and/or female when compared to patients without obesity. Among these patients, obesity may represent a barrier to transplant eligibility and a marker of inequity in heart transplantation and health outcomes in advanced heart failure.

Methods

To better understand this issue at our institution, we examined our active LVAD cohort and found that almost one-third of all patients had severe obesity with BMI ≥ 35 kg/m2.

Results

Patients with LVADs and severe obesity were significantly younger and more likely to self-identify as Black, and numerically more likely to be female.

Conclusion

Weight management in this group represents a vital area for improved equity in health outcomes and barriers to heart transplantation.

Trial Registration

NA.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American heart journal
American heart journal 医学-心血管系统
CiteScore
8.20
自引率
2.10%
发文量
214
审稿时长
38 days
期刊介绍: The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.
期刊最新文献
Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUS. Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications. Changes in coverage, access, and health status among adults with cardiovascular disease after medicaid work requirements. Impact of Moderate or Severe Mitral and Tricuspid Valves Regurgitation after Transcatheter Aortic Valve Replacement. Efficacy of Dual Antiplatelet therapy after Ischemic Stroke According to hsCRP Levels and CYP2C19 Genotype.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1